Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × veliparib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Hemangiosarcoma 1 Gliosarcoma 1 Glioblastoma 1 Ann Arbor Stage III Non-Hodgkin Lymphoma 1 Advanced Malignant Solid Neoplasm 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Specimen Handling 4 Nivolumab 4 Biopsy 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Immunoglobulin G 2 Bevacizumab 2 talimogene laherparepvec 1 sargramostim 1 regorafenib 1 prednylidene 1 deltacortene 1 decitabine and cedazuridine drug combination 1 avelumab 1 atezolizumab 1 aflibercept 1 X-Rays 1 Sirolimus 1 Radiosurgery 1 Prednisone 1 Paclitaxel 1 NEO212 1 MAPRE1 protein, human 1 Lidocaine, Prilocaine Drug Combination 1 IFL protocol 1 Disulfides 1 Cyclophosphamide 1 Colony-Stimulating Factors 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡